Advances in the research of intestinal fungi in Crohn's disease
- PMID: 39492826
- PMCID: PMC11525856
- DOI: 10.3748/wjg.v30.i39.4318
Advances in the research of intestinal fungi in Crohn's disease
Abstract
This article reviews of the original research published by Wu et al in the World Journal of Gastroenterology, delving into the pivotal role of the gut microbiota in the pathogenesis of Crohn's disease (CD). Insights were gained from fecal microbiota transplantation (FMT) in mouse models, revealing the intricate interplay between the gut microbiota, mesenteric adipose tissue (MAT), and creeping fat. The study uncovered the characteristics of inflammation and fibrosis in the MAT and intestinal tissues of patients with CD; moreover, through the FMT mouse model, it observed the impact of samples from healthy patients and those with CD on symptoms. The pathogenesis of CD is complex, and its etiology remains unclear; however, it is widely believed that gut microbiota dysbiosis plays a significant role. Recently, with the development and application of next-generation sequencing technology, research on the role of fungi in the pathogenesis and chronicity of CD has deepened. This editorial serves as a supplement to the research by Wu et al who discussed advances related to the study of fungi in CD.
Keywords: Crohn's disease pathogenesis; Fecal microbiota transplantation; Gut fungal dynamics; Intestinal microbiota; Mesenteric adipose tissue.
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors declare that they have no competing interests.
Similar articles
-
Interplay between creeping fat and gut microbiota: A brand-new perspective on fecal microbiota transplantation in Crohn's disease.World J Gastroenterol. 2025 Jan 14;31(2):100024. doi: 10.3748/wjg.v31.i2.100024. World J Gastroenterol. 2025. PMID: 39811513 Free PMC article.
-
Transplant of microbiota from Crohn's disease patients to germ-free mice results in colitis.Gut Microbes. 2024 Jan-Dec;16(1):2333483. doi: 10.1080/19490976.2024.2333483. Epub 2024 Mar 27. Gut Microbes. 2024. PMID: 38532703 Free PMC article.
-
Stem cell transplantation for induction of remission in medically refractory Crohn's disease.Cochrane Database Syst Rev. 2022 May 13;5(5):CD013070. doi: 10.1002/14651858.CD013070.pub2. Cochrane Database Syst Rev. 2022. PMID: 35556242 Free PMC article.
-
Role of gut microbiota in Crohn's disease pathogenesis: Insights from fecal microbiota transplantation in mouse model.World J Gastroenterol. 2024 Aug 21;30(31):3689-3704. doi: 10.3748/wjg.v30.i31.3689. World J Gastroenterol. 2024. PMID: 39193000 Free PMC article.
-
Enteral nutritional therapy for induction of remission in Crohn's disease.Cochrane Database Syst Rev. 2007 Jan 24;(1):CD000542. doi: 10.1002/14651858.CD000542.pub2. Cochrane Database Syst Rev. 2007. Update in: Cochrane Database Syst Rev. 2018 Apr 01;4:CD000542. doi: 10.1002/14651858.CD000542.pub3. PMID: 17253452 Updated.
Cited by
-
An Attempted Correlation Between the Fecal Microbial Community of Chinese Forest Musk Deer (Moschus berezovskii) and Differences in Musk Production and Quality.Animals (Basel). 2025 May 31;15(11):1622. doi: 10.3390/ani15111622. Animals (Basel). 2025. PMID: 40509088 Free PMC article.
-
Probiotic Saccharomyces boulardii Against Cronobacter sakazakii Infection: In Vitro and In Vivo Studies.Probiotics Antimicrob Proteins. 2025 Mar 21. doi: 10.1007/s12602-025-10524-3. Online ahead of print. Probiotics Antimicrob Proteins. 2025. PMID: 40113720
References
-
- Chen L, Su C, Ding H, Mei Q. Small molecules for inflammatory bowel disease and the risk of infection and malignancy: A systematic review and meta-Analysis. Dig Liver Dis. 2024 - PubMed
-
- Louis E, Schreiber S, Panaccione R, Bossuyt P, Biedermann L, Colombel JF, Parkes G, Peyrin-Biroulet L, D'Haens G, Hisamatsu T, Siegmund B, Wu K, Boland BS, Melmed GY, Armuzzi A, Levine P, Kalabic J, Chen S, Cheng L, Shu L, Duan WR, Pivorunas V, Sanchez Gonzalez Y, D'Cunha R, Neimark E, Wallace K, Atreya R, Ferrante M, Loftus EV Jr INSPIRE and COMMAND Study Group. Risankizumab for Ulcerative Colitis: Two Randomized Clinical Trials. JAMA. 2024;332:881–897. - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical